29265-79-0

Basic information

• Product Name: Benzene, 1-bromo-3-(1-phenylethenyl)-
• CAS NO: 29265-79-0
• Molecular Formula: C14H11Br
• Molecular Weight: 259.145
• Mol File: 29265-79-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-3-(1-phenylethenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-3-(1-phenylethenyl)-(29265-79-0)
• EPA Substance Registry System: Benzene, 1-bromo-3-(1-phenylethenyl)-(29265-79-0)

Safety Data

• Hazardous Substances Data: 29265-79-0(Hazardous Substances Data)

Upstream product

• 98-86-2 acetophenone 
• 14428-98-9 N-benzyl-N-(1-phenylethylidene)amine 
• 90006-76-1 3-methyl-3-phenyl-diaziridine 
• 89598-96-9 (3-bromophenyl)boronic acid 
• 63269-86-3 3-methyl-3-phenyl-3H-diazirine 
• 1016-77-9 3-bromobenzophenone 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 2142-63-4 1-(3-Bromophenyl)ethanone 
• 591-51-5 phenyllithium 

Downstream Products

• 384793-12-8 1-[3-((3-chloropropyl)dimethylsilyl)phenyl]-1-phenylethylene 
• 29265-83-6 3-(1-phenylethenyl)benzonitrile 

Relevant articles and documents

Preparation and morphology of ring-shaped polystyrene-block-polyisoprenes

Three polystyrene-block-polyisoprene-block-polystyrenes (SIS) with different compositions were prepared and cyclized by the coupling reaction between two end groups on the same molecules. Ring-shaped polystyrene-block-polyisoprenes (SI) were isolated from

Metal-free oxidative cross-coupling of diazirines with arylboronic acids

We report herein a metal-free cross-coupling of diazirines with arylboronic acids under oxidative conditions. The reaction affords a series of substituted olefins. It is proposed that the interaction between the nitrogen on diazirine with arylboronic acid plays a key role in this transformation.

4,5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES

The present invention relates to a compounds of formula I wherein R1, R1′, R2, R3, R4, X, Ar, and m are as defined in the specification and claims and pharmaceutically active acid addition salts thereof. Compounds of the invention have Asp2 (β-secretase, BACE 1 or Memapsin-2) inhibitory activity and are useful for the treatment of diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.